The PPARα antagonist GW6471 attenuated enhanced fatty-acid oxidation and oxidative phosphorylation, blocked enhanced glycolysis, and reduced tumor growth in a renal-cell carcinoma model in nude mice [194]. The gene discussed is PPARA; the disease is neoplasm.